| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |